Pleuropneumonia

Pleuropneumonia represents one of the most serious respiratory emergencies in horses, characterized by concurrent infection of the lung tissue (pneumonia) and accumulation of infected fluid or inflammatory material within the pleural space surrounding the lungs (pleuritis). This devastating condition can progress rapidly from subtle early signs to life-threatening respiratory compromise, sepsis, and death, making early recognition and aggressive treatment absolutely essential for survival. The combined assault on lung function from both parenchymal infection and pleural fluid compression creates a dangerous double threat that demands immediate veterinary intervention.

The condition occurs worldwide and affects horses of all breeds, ages, and uses, though certain populations face significantly elevated risk. The strong association with long-distance transport earned pleuropneumonia the colloquial name "shipping fever," reflecting the common presentation following trailer or air transport. Performance horses traveling to competitions, racehorses shipping between tracks, and sales horses undergoing transport demonstrate particularly high incidence. However, pleuropneumonia can also develop in horses that have not been transported, particularly following upper respiratory infection, general anesthesia, esophageal obstruction (choke), or any condition compromising normal respiratory clearance mechanisms.

The impact of pleuropneumonia on equine health extends well beyond survival of the acute crisis. Even with successful treatment, many horses experience permanent reduction in respiratory capacity due to lung scarring, pleural adhesion formation, and persistent pleural thickening that restrict lung expansion. Athletic careers may be shortened or ended entirely, with some studies suggesting only 50-70% of pleuropneumonia survivors return to their previous performance level. The extended hospitalization, intensive treatment requirements, and potential complications create substantial economic impact, with treatment costs potentially exceeding tens of thousands of dollars for severe cases.

Early detection dramatically influences pleuropneumonia outcomes, yet the condition often begins insidiously with signs easily attributed to routine travel stress or minor illness. Horses developing fever, depression, reduced appetite, or reluctance to move within days of transport warrant immediate veterinary evaluation rather than assumption that symptoms represent simple fatigue. Understanding the risk factors, recognizing early warning signs, and seeking prompt veterinary assessment when pleuropneumonia is suspected can mean the difference between successful treatment with potential return to function and loss of the horse or permanent disability.

The primary causes of pleuropneumonia involve bacterial infection of the lower respiratory tract, with Streptococcus species (particularly S. zooepidemicus and S. equi subspecies equi) being the most commonly isolated organisms. Other frequently identified bacteria include Pasteurella species, Actinobacillus species, Klebsiella pneumoniae, Escherichia coli, and various anaerobic bacteria. Mixed infections involving multiple bacterial species and both aerobic and anaerobic organisms occur commonly, complicating treatment decisions. These bacteria often represent opportunistic infection by organisms normally present in the horse's respiratory tract that overwhelm compromised host defenses.

Transport-associated factors explain the strong "shipping fever" association with pleuropneumonia. Prolonged trailer confinement with head elevation prevents normal postural drainage of respiratory secretions that normally occur when horses lower their heads to graze. Accumulated secretions provide ideal medium for bacterial proliferation. Transport stress suppresses immune function through cortisol elevation. Dehydration from reduced water intake during travel concentrates respiratory secretions. Poor air quality in trailers from exhaust fumes, dust, and ammonia damages respiratory epithelium. Commingling with horses from different sources exposes horses to novel pathogens while their defenses are compromised.

Environmental and management factors beyond transport contribute to pleuropneumonia development. Prior viral respiratory infection (influenza, rhinopneumonitis) damages the respiratory epithelium and cilia that normally clear bacteria from the airways. General anesthesia with head-elevated positioning impairs clearance and may allow aspiration. Esophageal obstruction (choke) can result in aspiration of feed material into the lungs. Nasogastric intubation and other medical procedures provide potential contamination pathways. Poor stable ventilation, dusty environments, and exposure to respiratory irritants compromise airway health.

Risk factors predisposing to pleuropneumonia include any condition compromising respiratory defenses or clearance mechanisms. Recent strenuous exercise before transport may suppress immunity. Concurrent illness or stress reduces resistance to infection. Extremes of age, with very young and older horses showing increased susceptibility. Poor nutritional status compromises immune function. Previous respiratory disease may leave residual vulnerability. Individual horses with naturally less efficient respiratory clearance mechanisms face elevated risk. Immunosuppression from any cause dramatically increases susceptibility.

The pathophysiology of pleuropneumonia involves progressive infection and inflammation. Initial bacterial colonization of the lower airways, perhaps from aspiration or extension from upper respiratory infection, establishes pneumonia in the lung parenchyma. As infection progresses, inflammation spreads to the visceral pleura covering the lung surface. Infected material and inflammatory exudate accumulate in the pleural space, initially as thin fluid that progressively thickens with fibrin deposition. This pleural effusion compresses the lung from outside while pneumonia destroys function from within. If infection enters the bloodstream, sepsis develops with systemic inflammatory response syndrome (SIRS), endotoxemia, and potential multiple organ dysfunction.

Early warning signs of pleuropneumonia often appear within 1-7 days following transport or other predisposing events, though presentation can be delayed weeks after apparent triggering factors. Initial symptoms may be subtle and easily dismissed as travel fatigue or minor illness. Horses may show mild depression, slightly reduced appetite, or reluctance to move freely. Low-grade fever (101-102.5°F) may be present intermittently or persistently. A soft cough, particularly with exercise or feeding, may develop. Horses may appear "off" in ways difficult to specifically characterize. Any horse developing these signs within two weeks of transport should be evaluated for possible pleuropneumonia.

Common symptoms of established pleuropneumonia become progressively more apparent and severe. Fever typically rises above 102°F and may reach 104-106°F, though horses in septic shock may become hypothermic. Increased respiratory rate (tachypnea) and increased respiratory effort become obvious, with nostril flaring, visible abdominal component to breathing, and reluctance to lie down due to respiratory compromise. Cough may progress from soft to harsh and painful. Purulent nasal discharge may be present, though its absence does not rule out pleuropneumonia. Depression deepens, and horses show marked decreased appetite or complete anorexia.

Behavioral changes in horses with pleuropneumonia reflect both respiratory distress and systemic illness. Affected horses often stand with elbows abducted (pointed outward) and head and neck extended to maximize airway opening. They may show reluctance to turn tightly or bend laterally due to chest pain. Lying down becomes avoided as recumbency further compromises already impaired breathing. Some horses grunt audibly with each breath, indicating chest pain. Anxiety and distress from air hunger may progress to exhaustion and obtundation as the condition worsens. Marked weight loss develops rapidly, reflecting both anorexia and the metabolic demands of severe infection.

Physical examination findings provide important diagnostic information. Heart rate elevation often reaches 60-80+ beats per minute, reflecting both fever and pain. Respiratory rate exceeds normal ranges and may be dramatically elevated. Auscultation of the chest reveals abnormal sounds including crackles, wheezes, or areas of absent sound where fluid accumulation prevents normal air movement. Percussion of the chest may demonstrate dullness ventrally where fluid accumulates with resonance dorsally over aerated lung. A horizontal fluid line may be appreciable on auscultation and percussion. Peripheral edema (particularly ventral and limb swelling) develops as protein is lost to pleural effusion.

Symptom progression in inadequately treated pleuropneumonia follows a devastating course. Respiratory distress worsens as pleural fluid accumulation increases and lung function deteriorates. Sepsis develops with increasingly rapid heart rate, altered mucous membrane color (progressing from bright to muddy or pale), prolonged capillary refill, and cold extremities. Laminitis may develop as a complication of sepsis and endotoxemia. Weight loss accelerates dramatically. Multi-organ dysfunction develops in severe cases. Without aggressive treatment, death from respiratory failure, septic shock, or complications can occur within days to weeks.

Emergency symptoms requiring immediate veterinary intervention include any horse with fever and respiratory signs, particularly following transport. Visible respiratory distress—marked nostril flaring, heaving breathing, extended head and neck—constitutes emergency regardless of history. Reluctance or inability to move, profound depression, or signs of shock (rapid weak pulse, cold extremities, pale membranes) demand immediate attention. Any horse deteriorating despite initial treatment requires reassessment. The classic presentation of fever, depression, and reluctance to move following transport should trigger pleuropneumonia evaluation before symptoms progress to more obvious respiratory distress.

Physical examination for suspected pleuropneumonia begins with assessment of vital parameters and respiratory status. Temperature measurement identifies fever, with some horses reaching 104-106°F. Heart and respiratory rates are typically elevated. Careful thoracic auscultation characterizes lung sounds, identifying areas of crackles, wheezes, increased bronchial sounds, or notably absent breath sounds ventrally where fluid accumulates. Percussion of the chest can demonstrate fluid lines separating ventral dullness from dorsal resonance. Rebreathing examination, where the horse's nose is covered briefly to intensify breathing effort, may accentuate abnormal sounds. Assessment of mucous membrane color, capillary refill time, and pulse quality evaluates systemic status.

Thoracic ultrasonography represents the most valuable diagnostic tool for pleuropneumonia, providing immediate, non-invasive assessment of pleural fluid accumulation and lung pathology. The examination identifies pleural effusion, characterizes its echogenicity (which helps predict whether drainage will be possible), measures fluid depth, and evaluates underlying lung surface for consolidation, abscessation, or surface irregularity. Fibrin strands within fluid or on pleural surfaces indicate advanced inflammatory changes. Serial ultrasonographic examinations monitor treatment response and guide decisions about drainage requirements.

Additional diagnostic tests extend evaluation and guide treatment. Complete blood count typically shows elevated white blood cell count with neutrophilia and left shift, though severe sepsis may cause neutropenia. Fibrinogen levels rise dramatically as an acute phase protein. Blood chemistry assesses organ function, protein levels, and electrolyte balance. Thoracocentesis (pleural fluid sampling) provides material for cytological analysis, bacterial culture, and sensitivity testing essential for targeted antibiotic therapy. Fluid character ranges from clear yellow through turbid to frankly purulent, with elevated cell counts and protein content. Transtracheal wash or bronchoalveolar lavage may identify lower airway pathogens. Arterial blood gas analysis quantifies respiratory compromise.

Differential diagnosis for horses presenting with fever, depression, and respiratory signs includes other conditions requiring distinction from pleuropneumonia. Simple pneumonia without pleural involvement causes similar signs but without the fluid accumulation pattern. Thoracic neoplasia may cause pleural effusion without infection. Cardiac disease can cause pleural effusion and respiratory signs. Peritonitis may be confused with pleuropneumonia, particularly when diaphragmatic involvement occurs. Upper respiratory infection typically causes less systemic illness and normal thoracic findings. Heaves (recurrent airway obstruction) causes respiratory distress without fever or systemic illness in chronic cases. Thoracic ultrasonography reliably identifies pleural effusion and guides distinction from these differentials.

Emergency treatment for pleuropneumonia begins immediately upon diagnosis with aggressive antimicrobial therapy and supportive care. Broad-spectrum intravenous antibiotics targeting both aerobic and anaerobic organisms initiate before culture results return, with combinations such as penicillin plus gentamicin or amikacin plus metronidazole commonly employed. Antibiotic selection is adjusted based on culture and sensitivity results once available, with treatment often continuing for 4-8 weeks or longer. Anti-inflammatory therapy with NSAIDs such as flunixin meglumine reduces fever, provides analgesia, and addresses endotoxemia effects. Intravenous fluid therapy corrects dehydration and supports cardiovascular function. Nutritional support maintains energy balance during prolonged illness.

Pleural drainage represents a critical component of treatment when significant effusion is present. Thoracocentesis removes accumulated fluid, relieving lung compression and removing infected material. Initial drainage may yield 10-30 or more liters from severely affected horses. The procedure can be performed through needle/catheter placement or surgically placed indwelling drains depending on fluid character and volume. Thick, fibrinous, or loculated fluid may require standing thoracotomy with rib resection to achieve adequate drainage. Pleural lavage, instilling large volumes of balanced polyionic fluid and draining repeatedly, helps remove debris and bacteria. Drainage procedures may need repetition daily or multiple times daily in severe cases.

Medical management beyond antibiotics and drainage addresses the multiple systemic effects of pleuropneumonia. Gastroprotection with omeprazole or other agents prevents stress ulceration. Hyperimmune plasma transfusion may provide benefit in severely affected horses. Bronchodilator therapy opens airways. Oxygen supplementation through nasal insufflation benefits horses in severe respiratory distress. Pain management ensures comfort and willingness to breathe deeply. Prevention of complications including laminitis through cryotherapy and support becomes important given sepsis risk. Monitoring and treatment of anemia developing from chronic infection may require blood transfusion in severe cases.

Surgical intervention may be necessary for cases with complicated pleural effusion. Standing thoracotomy with rib resection provides wide access for drainage and lavage when less invasive techniques prove inadequate. Creation of a surgical thoracostomy allows repeated or continuous drainage. Thoracoscopy (chest endoscopy) permits visualization and potential breakdown of adhesions or loculations. Pulmonary abscess drainage may be performed in selected cases. Surgical decisions balance the benefits of more aggressive drainage against the risks of procedures in compromised patients.

Long-term treatment considerations recognize that pleuropneumonia often requires extended therapy. Antibiotic courses typically span 6-12 weeks, sometimes longer, based on clinical and ultrasonographic response. Monitoring through serial ultrasound, blood work, and clinical assessment guides treatment duration decisions. Premature antibiotic discontinuation risks relapse. Discharge from hospital often occurs while treatment continues, with owners trained to administer oral or injectable medications at home. Gradual return to work proceeds only after complete resolution of clinical and ultrasonographic abnormalities.

Treatment decisions involve consideration of prognosis, cost, and individual case factors. Horses with mild disease and prompt treatment have favorable prognoses. Those with extensive bilateral involvement, abscessation, or severe sepsis face guarded outcomes. Treatment costs for severe cases with prolonged hospitalization can reach tens of thousands of dollars. Honest prognostic discussions help owners make informed decisions about treatment intensity. When prognosis is hopeless or the horse is suffering without prospect of meaningful recovery, humane euthanasia may be the most appropriate decision.

Recovery timeline for pleuropneumonia varies considerably based on severity and treatment response. Mild cases with early treatment may show significant improvement within 1-2 weeks, with hospital discharge possible at that time though treatment continues at home. Moderate cases typically require 3-6 weeks of hospitalization with several additional months of convalescence and ongoing treatment. Severe cases may require months of intensive therapy, with full recovery extending 6-12 months or longer. Horses requiring surgical drainage face additional recovery time related to the surgical site. Complete resolution of ultrasonographic abnormalities often lags behind clinical improvement by weeks to months.

Post-treatment care and monitoring establish protocols extending well beyond apparent clinical recovery. Antibiotic therapy continues for the full prescribed course, often 6-12 weeks, regardless of clinical improvement. Serial thoracic ultrasonography, typically weekly initially then biweekly to monthly, monitors pleural fluid resolution, adhesion development, and lung recovery. Blood work including fibrinogen levels tracks inflammatory response resolution. Body weight monitoring ensures nutritional adequacy during recovery. Gradual increase in activity follows veterinary assessment of readiness, with ultrasonographic clearance typically required before return to exercise.

Prognosis factors influencing long-term outcomes include initial disease severity, promptness of treatment initiation, presence of complications, and response to therapy. Horses with unilateral, non-loculated effusion that drains easily have favorable prognoses, with 70-90% survival and 60-80% return to athletic function. Bilateral involvement, extensive abscessation, or failure to respond to drainage worsens prognosis. Development of laminitis or other complications reduces survival rates. Presence of anaerobic organisms in culture suggests more severe disease. Duration of illness before treatment inversely correlates with outcome.

Long-term soundness and athletic potential depend on the extent of permanent respiratory damage. Many pleuropneumonia survivors return to previous performance levels, particularly those with mild disease and complete resolution. Others experience permanent reduction in respiratory capacity from pleural thickening and adhesions that restrict lung expansion, or from scarring within the lung parenchyma. These horses may function well for pleasure riding or light work but lack the respiratory reserve for high-level athletics. Some studies report only 50-60% of affected racehorses return to racing, with fewer returning to their pre-illness performance level. Honest assessment of each individual's respiratory capacity guides appropriate use decisions.

Management practices reducing pleuropneumonia risk focus primarily on safe transport protocols and maintenance of respiratory health. Transport duration should be minimized where possible, with breaks every 4-6 hours allowing horses to lower their heads and clear respiratory secretions. Adequate ventilation in trailers reduces pathogen concentration and respiratory irritant exposure. Avoiding transport during extreme temperatures and ensuring water availability during transport maintains hydration. Rest periods of at least 24 hours before transport following strenuous exercise allows recovery of immune function. Avoiding transport of horses showing any signs of respiratory illness prevents progression to pleuropneumonia.

Vaccination and biosecurity measures provide foundation respiratory protection. Current vaccination against equine influenza and rhinopneumonitis (equine herpesvirus) reduces viral infections that predispose to bacterial pleuropneumonia. Quarantine protocols for new arrivals minimize pathogen introduction to resident populations. Avoiding overcrowded conditions and commingling of horses from multiple sources reduces respiratory pathogen exposure. Good ventilation in barns maintains air quality that supports respiratory health.

Nutritional and general health maintenance supports immune function and respiratory defenses. Adequate protein, vitamins, and minerals maintain tissue integrity and immune competence. Avoiding stressors that suppress immunity, including overtraining, extreme weather exposure, and social stress, preserves resistance to infection. Regular deworming and dental care maintain overall health. Prompt attention to any illness prevents progression that could compromise respiratory function.

Environmental factors affecting respiratory health deserve attention. Dust control through arena watering, low-dust bedding selection, and adequate ventilation reduces respiratory irritant exposure. Avoiding moldy hay and feed eliminates a major source of respiratory fungal exposure. Pasture turnout, where feasible, provides superior air quality compared to stabled environments. Climate considerations may dictate timing of transport to avoid extreme heat or cold.

Post-transport monitoring enables early detection if pleuropneumonia does develop despite preventive measures. Temperature monitoring twice daily for 7-14 days following transport identifies fever before other symptoms develop. Observation for depression, reduced appetite, or reluctance to move catches early cases. Any abnormality warrants veterinary evaluation rather than assumption that symptoms represent simple travel fatigue. Early detection and treatment dramatically improve pleuropneumonia outcomes.

Daily management adjustments for horses recovering from pleuropneumonia emphasize respiratory support and gradual return to function. Environmental air quality becomes paramount—dust-free bedding, well-ventilated housing, and avoidance of respiratory irritants support healing lungs. Feeding from ground level encourages natural postural drainage of respiratory secretions. Nutritional support with high-quality, palatable feeds addresses the profound weight loss typically accompanying pleuropneumonia. Small, frequent meals may be better tolerated than large feedings. Recording daily observations including temperature, respiratory rate, appetite, and attitude monitors for improvement or deterioration.

Housing and turnout considerations balance recovery needs with appropriate activity. Initial recovery typically requires stall rest with only hand walking for exercise. Turnout gradually increases as clinical and ultrasonographic findings improve. Pasture environments provide superior air quality compared to barns. Weather protection remains important as recovering horses may have less tolerance for environmental extremes. Avoiding dusty arenas, freshly bedded stalls, or hay feeding areas reduces respiratory challenge during recovery.

Exercise modifications follow careful progression based on veterinary assessment. Hand walking begins early in recovery, supporting circulation and preventing complications of prolonged stall rest without stressing the respiratory system. Duration gradually increases as tolerated. Introduction of trotting work occurs only after significant clinical and ultrasonographic improvement, typically several weeks to months post-diagnosis. Cantering and more demanding exercise resume only after thoracic ultrasonography shows resolution of effusion and lung pathology. Full return to athletic work may take 6-12 months for severely affected horses.

Monitoring and ongoing care extend throughout the prolonged recovery period. Serial thoracic ultrasonography guides exercise progression and treatment duration decisions. Blood work monitoring tracks inflammatory marker resolution. Body weight assessment ensures adequate nutritional intake. Observation for any recurrence of fever, depression, or respiratory signs enables prompt response if relapse occurs. Documentation of the illness, treatment course, and recovery provides valuable information for future management and any sale or transfer of the horse.

Quality of life and use considerations evolve as recovery progresses and permanent damage extent becomes apparent. Many pleuropneumonia survivors return to full previous function including demanding athletic pursuits. Those with significant residual pleural thickening or lung scarring may have permanently reduced respiratory capacity affecting exercise tolerance. Realistic assessment of each individual's respiratory capability guides appropriate use decisions. Horses unable to return to high-level athletics may function well as pleasure horses, trail horses, or in lower-intensity disciplines. The goal is matching each horse's capabilities with appropriate expectations, enabling good quality of life regardless of ultimate athletic potential.

High-risk breeds for pleuropneumonia relate primarily to use patterns and management rather than genetic susceptibility. Thoroughbreds and Standardbreds in racing demonstrate elevated incidence due to frequent long-distance transport between training centers, racetracks, and sales venues combined with the immunosuppressive effects of intense training. Warmblood sport horses competing at high levels face similar transport-associated risks. Quarter Horses engaged in competitive circuits requiring regular transport show corresponding pleuropneumonia rates. Any breed of horse subject to long-distance shipping shares this transport-associated risk regardless of genetic background.

Use and discipline considerations strongly influence pleuropneumonia risk. Performance horses across all breeds face elevated risk due to transport frequency, competitive stress, and intensive management. Young horses in sales consignment experience significant transport, commingling, and stress during vulnerable periods. Breeding stock shipped between farms for breeding or sale face transport risks. Show horses with busy competition schedules involving frequent trailer trips accumulate exposure. Conversely, horses maintained at single locations with minimal transport face much lower pleuropneumonia risk regardless of breed or use.

Genetic testing and breeding recommendations for pleuropneumonia focus on management rather than genetic selection since the condition lacks known hereditary basis. However, selection for robust immune function and respiratory health may indirectly reduce susceptibility across populations. Horses with history of pleuropneumonia should be considered higher risk for future episodes, affecting decisions about continued competitive use and transport frequency. Documentation of pleuropneumonia history provides important information for prospective buyers or future managers. Breeding decisions need not specifically address pleuropneumonia susceptibility, though overall health and vigor remain appropriate selection criteria.

Commonly co-occurring conditions with pleuropneumonia include the predisposing factors that enabled its development. Upper respiratory infections, particularly equine influenza and equine herpesvirus, frequently precede pleuropneumonia by damaging respiratory defenses. Strangles (Streptococcus equi) infection may progress to involve the lower respiratory tract. Aspiration events from choke, reflux, or improper nasogastric intubation introduce contamination. The systemic effects of pleuropneumonia frequently trigger laminitis as a complication. Disseminated intravascular coagulation (DIC) may develop in septic cases. Weight loss and muscle wasting represent nearly universal accompanying findings.

Conditions with similar symptoms requiring differentiation include other causes of fever, depression, and respiratory signs. Simple pneumonia without pleural involvement causes similar respiratory signs but without the fluid accumulation pattern identifiable on ultrasound. Thoracic neoplasia may cause pleural effusion and respiratory compromise. Cardiac disease with pleural effusion may mimic pleuropneumonia. Peritonitis causes systemic illness that may include respiratory signs. Upper respiratory infection typically causes less systemic compromise. Exercise-induced pulmonary hemorrhage causes respiratory issues of different character. Thoracic ultrasonography most reliably distinguishes pleuropneumonia from these differentials by demonstrating the characteristic pleural fluid and lung pathology.

Potential complications of pleuropneumonia extend beyond the primary disease. Laminitis represents a serious complication of the sepsis and endotoxemia associated with pleuropneumonia. Pleural adhesion formation restricts lung expansion and may cause chronic respiratory limitation. Lung abscessation may develop within consolidated pulmonary tissue, requiring prolonged treatment. Pericarditis (infection of the heart sac) occasionally develops by extension from adjacent pleural disease. Chronic weight loss and poor condition may persist for months. Jugular vein thrombophlebitis from prolonged intravenous catheterization affects future medication administration options. Recognition of these potential complications guides monitoring and management throughout recovery.